{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:20:07Z","timestamp":1790882407127,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejim.2014.10.021","type":"journal-article","created":{"date-parts":[[2014,11,16]],"date-time":"2014-11-16T19:58:49Z","timestamp":1416167929000},"page":"900-908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Developing a list of high-alert medications for patients with chronic diseases"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6468-8842","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Otero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Moreno-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Santos-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Agra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2014.10.021_bb0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jhrm.5600180104","article-title":"Survey of hospital systems and common serious medication errors","volume":"18","author":"Cohen","year":"1998","journal-title":"J Health Risk Manag"},{"key":"10.1016\/j.ejim.2014.10.021_bb0010","series-title":"Medication errors","first-page":"317","article-title":"High-alert medications: safeguarding against errors","author":"Cohen","year":"2007"},{"key":"10.1016\/j.ejim.2014.10.021_bb0015","series-title":"ISMP's list of high-alert medications","author":"Institute for Safe Medication Practices","year":"2012"},{"key":"10.1016\/j.ejim.2014.10.021_bb0020","series-title":"Sentinel event alert 11","article-title":"High-alert medications and patient safety","author":"Joint Commission on Accreditation of Healthcare Organization","year":"1999"},{"key":"10.1016\/j.ejim.2014.10.021_bb0025","series-title":"The \u201chow to guide\u201d for reducing harm from high risk medicines","article-title":"Patient safety first","author":"National Patient Safety Agency","year":"2008"},{"key":"10.1016\/j.ejim.2014.10.021_bb0030","series-title":"How-to guide: prevent harm from high-alert medications","author":"Institute for Healthcare Improvement","year":"2012"},{"key":"10.1016\/j.ejim.2014.10.021_bb0035","series-title":"National Quality Forum (NQF). Safe practices for better healthcare\u20142010 update: a consensus report","author":"The National Quality Forum","year":"2010"},{"key":"10.1016\/j.ejim.2014.10.021_bb0040","series-title":"Preventing chronic diseases: a vital investment","author":"World Health Organization","year":"2005"},{"key":"10.1016\/j.ejim.2014.10.021_bb0045","series-title":"European Observatory on Health Systems and Policies","article-title":"Tackling chronic disease in Europe. Strategies, interventions and challenges","author":"Busse","year":"2010"},{"key":"10.1016\/j.ejim.2014.10.021_bb0050","series-title":"Living well with chronic illness: a call for public health action","author":"Institute of Medicine","year":"2012"},{"key":"10.1016\/j.ejim.2014.10.021_bb0055","series-title":"Estrategia para el Abordaje de la Cronicidad en el Sistema Nacional de Salud","year":"2012"},{"key":"10.1016\/j.ejim.2014.10.021_bb0060","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1331\/JAPhA.2012.10145","article-title":"Risk models to improve safety of dispensing high-alert medications in community pharmacies","volume":"52","author":"Cohen","year":"2012","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.ejim.2014.10.021_bb0065","series-title":"The RAND\/UCLA appropriateness method user's manual","author":"Fitch","year":"2001"},{"key":"10.1016\/j.ejim.2014.10.021_bb0070","first-page":"258","article-title":"Utilizaci\u00f3n del CMBD como herramienta para la detecci\u00f3n de acontecimientos adversos a medicamentos","volume":"28","author":"Corral Baena","year":"2004","journal-title":"Farm Hosp"},{"key":"10.1016\/j.ejim.2014.10.021_bb0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2014.10.021_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1130-6343(06)73967-8","article-title":"Prevalencia y factores asociados a los acontecimientos adversos prevenibles por medicamentos que causan el ingreso hospitalario","volume":"30","author":"Otero L\u00f3pez","year":"2006","journal-title":"Farm Hosp"},{"key":"10.1016\/j.ejim.2014.10.021_bb0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which drugs cause preventable admissions to hospital? A systematic review","volume":"63","author":"Howard","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2014.10.021_bb0090","first-page":"1890","article-title":"Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands","volume":"168","author":"Leendertse","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0095","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archinternmed.2011.215","article-title":"Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients","volume":"171","author":"Hamilton","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0100","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0105","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.296.15.1858","article-title":"National surveillance of emergency department visits for outpatient adverse drug events","volume":"296","author":"Budnitz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2014.10.021_bb0110","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/gerona\/61.5.511","article-title":"Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay","volume":"61","author":"Hanlon","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ejim.2014.10.021_bb0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amjmed.2004.09.018","article-title":"The incidence of adverse drug events in two large academic long-term care facilities","volume":"118","author":"Gurwitz","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/qhc.12.4.280","article-title":"Investigation into the reasons for preventable drug related admissions to a medical admission unit: observational study","volume":"12","author":"Howard","year":"2003","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.ejim.2014.10.021_bb0125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-147-11-200712040-00006","article-title":"Medication use leading to emergency department visits for adverse drug events in older adults","volume":"147","author":"Budnitz","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/intqhc\/mzs015","article-title":"Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm","volume":"24","author":"Kalisch","year":"2012","journal-title":"Int J Qual Health Care"},{"issue":"348","key":"10.1016\/j.ejim.2014.10.021_bb0135","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJMsa020703","article-title":"Adverse drug events in ambulatory care","volume":"17","author":"Gandhi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/00002018-200831060-00009","article-title":"Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients","volume":"31","author":"Franceschi","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2014.10.021_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1157\/13116153","article-title":"An\u00e1lisis retrospectivo de los acontecimientos adversos por medicamentos en pacientes ancianos en un centro de salud de atenci\u00f3n primaria","volume":"40","author":"Al\u00f3s Almi\u00f1ana","year":"2008","journal-title":"Aten Primaria"},{"key":"10.1016\/j.ejim.2014.10.021_bb0150","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s00134-007-0787-8","article-title":"Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital","volume":"33","author":"Grenouillet-Delacre","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.amjmed.2006.07.045","article-title":"The safety of warfarin therapy in the nursing home setting","volume":"120","author":"Gurwitz","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0160","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1345\/aph.1R094","article-title":"Drug-related problems and hospital admissions in cardiac transplant recipients","volume":"46","author":"Repp","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.ejim.2014.10.021_bb0165","article-title":"Top 10 drugs reported as causing harm through medication error","volume":"6","author":"Institute for Safe Medication Practices Canada","year":"2006","journal-title":"ISMP Can Saf Bull"},{"issue":"3","key":"10.1016\/j.ejim.2014.10.021_bb0170","first-page":"1","article-title":"Medication incidents involving digoxin leading to harm, including death","volume":"11","author":"Institute for Safe Medication Practices Canada","year":"2011","journal-title":"ISMP Can Saf Bull"},{"issue":"1","key":"10.1016\/j.ejim.2014.10.021_bb0175","first-page":"1","article-title":"Anticoagulant safety takes center stage in 2007","volume":"12","author":"Institute for Safe Medication Practices","year":"2007","journal-title":"ISMP Medication Saf Alert"},{"key":"10.1016\/j.ejim.2014.10.021_bb0180","article-title":"Actions that can make anticoagulant therapy safer","volume":"18","author":"National Patient Safety Agency","year":"2007","journal-title":"Patient Saf Alert"},{"key":"10.1016\/j.ejim.2014.10.021_bb0185","series-title":"Warfarin (revised). Safety notice 006\/07","author":"New South Wales Health","year":"2007"},{"key":"10.1016\/j.ejim.2014.10.021_bb0190","series-title":"Safety notice 014\/11","article-title":"Newer oral anticoagulants","author":"New South Wales Health","year":"2011"},{"issue":"11","key":"10.1016\/j.ejim.2014.10.021_bb0195","first-page":"1","article-title":"An estimated 2 to 4 million drug-induced serious injuries in 2011","volume":"17","author":"Institute for Safe Medication Practices","year":"2012","journal-title":"ISMP Medication Saf Alert"},{"issue":"9","key":"10.1016\/j.ejim.2014.10.021_bb0200","article-title":"Medication incidents occurring in long-term care","volume":"10","author":"Institute for Safe Medication Practices Canada","year":"2010","journal-title":"ISMP Can Saf Bull"},{"issue":"8","key":"10.1016\/j.ejim.2014.10.021_bb0205","article-title":"Deaths associated with mediation incidents: learning from collaborative work with provincial offices of the Chief Coroner and Chief Medical Examiner","volume":"13","author":"Institute for Safe Medication Practices Canada","year":"2013","journal-title":"ISMP Can Saf Bull"},{"key":"10.1016\/j.ejim.2014.10.021_bb0210","series-title":"Rapid response report 014","article-title":"Reducing treatment dose errors with low molecular weight heparins","author":"National Patient Safety Agency","year":"2010"},{"issue":"4","key":"10.1016\/j.ejim.2014.10.021_bb0215","article-title":"Insulin errors","volume":"3","author":"Institute for Safe Medication Practices Canada","year":"2003","journal-title":"ISMP Can Saf Bull"},{"key":"10.1016\/j.ejim.2014.10.021_bb0220","series-title":"Complexity of insulin therapy has risen sharply in the past decade","first-page":"1","article-title":"Institute for safe medication practices","volume":"3(1)","year":"2004"},{"key":"10.1016\/j.ejim.2014.10.021_bb0225","series-title":"Medication PEN injectors: Not without ImPENding risks","first-page":"1","article-title":"Institute for Safe Medication Practices.","volume":"6(1)","year":"2007"},{"key":"10.1016\/j.ejim.2014.10.021_bb0230","series-title":"Medication errors with the dosing of insulin: problems across the continuum","first-page":"9","article-title":"Pennsylvania patient safety reporting system","volume":"7(1)","year":"2010"},{"key":"10.1016\/j.ejim.2014.10.021_bb0235","series-title":"Patient safety alert 003","article-title":"The adult patient's passport to safer use of insulin","author":"National Patient Safety Agency","year":"2011"},{"key":"10.1016\/j.ejim.2014.10.021_bb0240","series-title":"Oral antidiabetic therapy: not as easy as it used to be","first-page":"1","article-title":"Institute for Safe Medication Practices","volume":"3(8)","year":"2004"},{"key":"10.1016\/j.ejim.2014.10.021_bb0245","series-title":"Oral antidiabetic therapy: not as easy as it used to be (Part 2)","first-page":"1","article-title":"Institute for Safe Medication Practices","volume":"3(9)","year":"2004"},{"key":"10.1016\/j.ejim.2014.10.021_bb0250","series-title":"Colchicina: casos de sobredosis graves por errores de medicaci\u00f3n. Nota informativa 2010\/11","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2010"},{"issue":"4","key":"10.1016\/j.ejim.2014.10.021_bb0255","first-page":"1","article-title":"Reducing patient harm from opiates","volume":"12","author":"Institute for Safe Medication Practices","year":"2007","journal-title":"ISMP Medication Saf Alert"},{"key":"10.1016\/j.ejim.2014.10.021_bb0260","series-title":"Rapid Response Report 05","article-title":"Reducing dosing errors with opioid medicines","author":"National Patient Safety Agency","year":"2008"},{"issue":"12","key":"10.1016\/j.ejim.2014.10.021_bb0265","article-title":"Opioid-related incident in a long-term care home","volume":"12","author":"Institute for Safe Medication Practices Canada","year":"2012","journal-title":"ISMP Can Saf Bull"},{"key":"10.1016\/j.ejim.2014.10.021_bb0270","series-title":"New safety warnings about fentanyl patches\u2014part 1","first-page":"1","article-title":"Institute for Safe Medication Practices. Little patches\u2026Big problems","volume":"4(8)","year":"2005"},{"key":"10.1016\/j.ejim.2014.10.021_bb0275","series-title":"New safety warnings about fentanyl patches\u2014part 2","first-page":"1","article-title":"Institute for Safe Medication Practices. Little patches\u2026Big problems","volume":"4(9)","year":"2005"},{"key":"10.1016\/j.ejim.2014.10.021_bb0280","series-title":"New fentanyl warnings: more needed to protect patients","article-title":"Institute for Safe Medication Practices Canada","volume":"10(16)","year":"2005"},{"key":"10.1016\/j.ejim.2014.10.021_bb0285","series-title":"Analgesic skin patches","author":"New South Wales Health","year":"2006"},{"issue":"5","key":"10.1016\/j.ejim.2014.10.021_bb0290","article-title":"Transdermal fentanyl: a misunderstood dosage form","volume":"6","author":"Institute for Safe Medication Practices Canada","year":"2006","journal-title":"ISMP Can Saf Bull"},{"issue":"10","key":"10.1016\/j.ejim.2014.10.021_bb0295","first-page":"1","article-title":"Analysis of international findings from incidents involving fentanyl transdermal patches","volume":"9","author":"Institute for Safe Medication Practices Canada","year":"2009","journal-title":"ISMP Can Saf Bull"},{"key":"10.1016\/j.ejim.2014.10.021_bb0300","series-title":"Be on the lookout for oxycodone mix-ups","first-page":"1","article-title":"Institute for Safe Medication Practices","volume":"5(1)","year":"2006"},{"issue":"9","key":"10.1016\/j.ejim.2014.10.021_bb0305","first-page":"1","article-title":"Shared learning \u2014 reported incidents involving hydromorphone","volume":"6","author":"Institute for Safe Medication Practices Canada","year":"2006","journal-title":"ISMP Can Saf Bull"},{"key":"10.1016\/j.ejim.2014.10.021_bb0310","series-title":"Safety notice 011\/10","article-title":"Medication incidents involving hydromorphone (opioid)","author":"New South Wales Health","year":"2010"},{"key":"10.1016\/j.ejim.2014.10.021_bb0315","series-title":"Safety alert 004\/11","article-title":"HYDROmorphone: high-risk analgesic","author":"New South Wales Health","year":"2011"},{"issue":"21","key":"10.1016\/j.ejim.2014.10.021_bb0320","first-page":"1","article-title":"FDA approves HYDROmorphone labelling revisions to reduce medication errors","volume":"16","author":"Institute for Safe Medication Practices","year":"2011","journal-title":"ISMP Medication Saf Alert"},{"key":"10.1016\/j.ejim.2014.10.021_bb0325","series-title":"Keeping patients safe from iatrogenic methadone overdoses","first-page":"1","volume":"7(2)","author":"Institute for Safe Medication Practices","year":"2008"},{"key":"10.1016\/j.ejim.2014.10.021_bb0330","series-title":"Safety notice 013\/11","article-title":"Management of medication for patients with Parkinson's Disease (PD)","author":"New South Wales Health","year":"2011"},{"key":"10.1016\/j.ejim.2014.10.021_bb0335","series-title":"Patient safety alert 005","article-title":"Safer lithium therapy","author":"National Patient Safety Agency","year":"2009"},{"issue":"3","key":"10.1016\/j.ejim.2014.10.021_bb0340","article-title":"Drug interaction incident with HIV post-exposure prophylaxis","volume":"8","author":"Institute for Safe Medication Practices Canada","year":"2008","journal-title":"ISMP Can Saf Bull"},{"key":"10.1016\/j.ejim.2014.10.021_bb0345","series-title":"Rapid response report 001","article-title":"Risks of incorrect dosing of oral anti-cancer medicines","author":"National Patient Safety Agency","year":"2008"},{"key":"10.1016\/j.ejim.2014.10.021_bb0350","series-title":"Methotrexate overdose due to inadvertent daily administration instead of weekly","first-page":"1","article-title":"Institute for Safe Medication Practices","volume":"2(1)","year":"2003"},{"key":"10.1016\/j.ejim.2014.10.021_bb0355","series-title":"Policy directive 2005_624","article-title":"Methotrexate \u2014 safe use of oral methotrexate","author":"New South Wales Health","year":"2005"},{"key":"10.1016\/j.ejim.2014.10.021_bb0360","series-title":"Patient safety alert n\u00b013","article-title":"Improving compliance with oral methotrexate guidelines","author":"National Patient Safety Agency","year":"2006"},{"issue":"2","key":"10.1016\/j.ejim.2014.10.021_bb0365","article-title":"Incidents of inadvertent daily administration of methotrexate","volume":"8","author":"Institute for Safe Medication Practices Canada","year":"2008","journal-title":"ISMP Can Saf Bull"},{"key":"10.1016\/j.ejim.2014.10.021_bb0370","series-title":"Nota informativa de Seguridad 11\/2011","article-title":"Metotrexato por v\u00eda oral: reacciones adversas graves derivadas de la confusi\u00f3n en la dosis administrada","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2011"},{"key":"10.1016\/j.ejim.2014.10.021_bb0375","series-title":"Safety notice 011\/09","article-title":"Allopurinol and azathioprine","author":"New South Wales Health","year":"2009"},{"issue":"5","key":"10.1016\/j.ejim.2014.10.021_bb0380","article-title":"Prograf and advagraf mix-up","volume":"9","author":"Institute for Safe Medication Practices Canada","year":"2009","journal-title":"ISMP Can Saf Bull"},{"key":"10.1016\/j.ejim.2014.10.021_bb0385","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02600255","article-title":"Relationship between medication errors and adverse drug events","volume":"10","author":"Bates","year":"1995","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ejim.2014.10.021_bb0390","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1001\/jama.2011.1820","article-title":"Improving ambulatory patient safety. Learning from the last decade, moving ahead in the next","volume":"306","author":"Wynia","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2014.10.021_bb0395","series-title":"A Global challenge","article-title":"Safer primary care","author":"The Safer Primary Care Expert Working Group","year":"2012"},{"key":"10.1016\/j.ejim.2014.10.021_bb0400","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6904-12-5","article-title":"Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement","volume":"12","author":"Dreischulte","year":"2012","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.ejim.2014.10.021_bb0405","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/11596000-000000000-00000","article-title":"Targeting outpatient drug safety. Recommendations of the Dutch HARM-Wrestling Task Force","volume":"35","author":"Warl\u00e9-van Herwaarden","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2014.10.021_bb0410","series-title":"Utilizaci\u00f3n de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a durante el periodo 2000\u20132012","article-title":"Informe de utilizaci\u00f3n de medicamentos U\/HAY\/V1\/17012014","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2014"},{"key":"10.1016\/j.ejim.2014.10.021_bb0415","doi-asserted-by":"crossref","first-page":"g1996","DOI":"10.1136\/bmj.g1996","article-title":"Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study","volume":"348","author":"Weich","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2014.10.021_bb0420","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios"},{"issue":"1","key":"10.1016\/j.ejim.2014.10.021_bb0425","first-page":"e1","article-title":"Programas de optimizaci\u00f3n de uso de antimicrobianos (PROA) en hospitales espa\u00f1oles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH","volume":"30","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Enf Inf Microb Clin"},{"key":"10.1016\/j.ejim.2014.10.021_bb0430","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0048-7120(01)73220-3","article-title":"M\u00e9todos de consenso. Uso adecuado de la evidencia en la toma de decisiones \u201cM\u00e9todo RAND\/ UCLA\u201d","volume":"35","author":"Mart\u00ednez-Sahuquillo Amuedo","year":"2001","journal-title":"Rehabilitaci\u00f3n (Madr)"},{"key":"10.1016\/j.ejim.2014.10.021_bb0435","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2010.12.001","article-title":"Methods of formal consensus in classification\/diagnostic criteria and guideline development","volume":"41","author":"Nair","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2014.10.021_bb0440","first-page":"617","article-title":"Beers criteria update expert panel. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults","volume":"60","author":"The American Geriatrics Society","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2014.10.021_bb0445","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CPP46072","article-title":"STOPP (Screening Tool of Older Person\u2019's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment)","volume":"46","author":"Gallagher","year":"2008","journal-title":"Consensus validation, Int J Clin Pharmacol Ther"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514003033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514003033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T15:51:11Z","timestamp":1538063471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620514003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":89,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0953620514003033"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2014.10.021","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing a list of high-alert medications for patients with chronic diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2014.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}